Protein Signature Predicts Response to Neoadjuvant Treatment With Chemotherapy and Bevacizumab in HER2-Negative Breast Cancers CSF and blood were collected simultaneously from patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results